COMMUNIQUÉS West-GlobeNewswire

-
ADA 2025: Novo Nordisk highlights strong portfolio data with new semaglutide and CagriSema results, redefining possibilities in obesity and diabetes care
10/06/2025 -
Ashvattha Therapeutics to Present Phase 2 DME and Wet AMD Data at Clinical Trials at the Summit and MaculArt
10/06/2025 -
Noom Expands Board of Directors with Appointment of Global Health Leader Dr. David Luu
10/06/2025 -
Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
10/06/2025 -
Vivani Medical to Present at the 2025 BIO International Convention
10/06/2025 -
Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium
10/06/2025 -
Enlivex Therapeutics to Present Clinical Data of Allocetra in Osteoarthritis at EULAR 25 European Congress of Rheumatology
10/06/2025 -
GSAC Engineering Secures Multi-Year Recurring Revenue Contract
10/06/2025 -
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025
10/06/2025 -
Rose Hill Life Sciences to Spotlight Leading Research Partners at Psychedelic Science 2025
10/06/2025 -
Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development
10/06/2025 -
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program
10/06/2025 -
Iovance Biotherapeutics to Present at Upcoming Conference
10/06/2025 -
Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin for Treatment of MASH Cirrhosis and Portal Hypertension
10/06/2025 -
Roji Health Intelligence Achieves HITRUST e1 Certification Demonstrating Foundational Cybersecurity
10/06/2025 -
NeuroSigma Announces Notice of Allowance for Patent Protecting Monarch eTNS System in China
10/06/2025 -
Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
10/06/2025 -
Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution
10/06/2025 -
Ernexa Therapeutics Announces 1-for-15 Reverse Stock Split
10/06/2025
Pages